Haemonetics Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4050241003
USD
55.12
0.75 (1.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
1,334.03
1,360.82
1,309.06
1,168.66
993.20
870.46
988.48
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,334.03
1,360.82
1,309.06
1,168.66
993.20
870.46
988.48
Raw Material Cost
590.44
645.50
632.52
578.43
515.04
474.85
479.46
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
28.70
9.89
16.50
15.88
18.50
12.43
16.74
Selling and Distribution Expenses
442.42
431.85
416.17
373.95
320.93
269.40
284.00
Other Expenses
3.11
5.12
3.57
3.32
2.75
1.93
1.33
Total Expenditure (Excl Depreciation)
1,092.63
1,138.48
1,100.92
1,001.46
881.95
775.94
793.45
Operating Profit (PBDIT) excl Other Income
241.4
222.3
208.1
167.2
111.19999999999999
94.5
195
Other Income
0.00
1.74
3.97
-0.74
9.60
32.81
0.00
Operating Profit (PBDIT)
397.12
339.67
309.33
259.77
218.60
211.62
305.32
Interest
28.70
9.89
16.50
15.88
18.50
12.43
16.74
Exceptional Items
-84.67
-2.13
-43.75
-9.19
-38.72
-41.99
-91.13
Gross Profit (PBDT)
743.59
715.33
676.54
590.23
478.16
395.62
509.02
Depreciation
155.72
115.59
97.22
93.31
97.75
84.29
110.29
Profit Before Tax
128.03
212.07
151.87
141.40
63.63
72.91
87.15
Tax
30.72
44.39
34.31
26.00
20.25
-6.56
10.63
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
97.31
167.68
117.56
115.40
43.38
79.47
76.53
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
97.31
167.68
117.56
115.40
43.38
79.47
76.53
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
97.31
167.68
117.56
115.40
43.38
79.47
76.53
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
796.32
820.84
959.96
818.00
749.42
731.67
587.11
Earnings per share (EPS)
2.05
3.31
2.29
2.24
0.84
1.55
1.48
Diluted Earnings per share
2.05
3.31
2.29
2.24
0.84
1.55
1.48
Operating Profit Margin (Excl OI)
18.1%
16.34%
15.9%
14.31%
11.2%
10.86%
19.73%
Gross Profit Margin
21.27%
24.08%
19.03%
20.08%
16.25%
18.06%
19.97%
PAT Margin
7.29%
12.32%
8.98%
9.87%
4.37%
9.13%
7.74%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is -1.97% vs 3.95% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is -41.98% vs 42.60% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 17.52% vs 10.64% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 189.90% vs -40.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Compare Annual Results Of Haemonetics Corp. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
1,334.03
2,719.50
-1,385.47
-50.95%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,334.03
2,719.50
-1,385.47
-50.95%
Raw Material Cost
590.44
1,223.20
-632.76
-51.73%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
28.70
36.60
-7.90
-21.58%
Selling and Distribution Expenses
442.42
1,136.90
-694.48
-61.09%
Other Expenses
3.11
7.74
-4.63
-59.82%
Total Expenditure (Excl Depreciation)
1,092.63
2,474.10
-1,381.47
-55.84%
Operating Profit (PBDIT) excl Other Income
241.40
245.40
-4.00
-1.63%
Other Income
0.00
-2.30
2.30
100.00%
Operating Profit (PBDIT)
397.12
359.10
38.02
10.59%
Interest
28.70
36.60
-7.90
-21.58%
Exceptional Items
-84.67
-29.30
-55.37
-188.98%
Gross Profit (PBDT)
743.59
1,496.30
-752.71
-50.30%
Depreciation
155.72
116.00
39.72
34.24%
Profit Before Tax
128.03
177.20
-49.17
-27.75%
Tax
30.72
130.20
-99.48
-76.41%
Provisions and contingencies
0
0
0.00
Profit After Tax
97.31
47.00
50.31
107.04%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
97.31
47.00
50.31
107.04%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
97.31
47.00
50.31
107.04%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
796.32
3,106.30
-2,309.98
-74.36%
Earnings per share (EPS)
2.05
0.28
1.77
632.14%
Diluted Earnings per share
2.05
0.28
1.77
632.14%
Operating Profit Margin (Excl OI)
18.10%
9.02%
0.00
9.08%
Gross Profit Margin
21.27%
10.78%
0.00
10.49%
PAT Margin
7.29%
1.73%
0.00
5.56%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 133.40 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is -1.97% vs 3.95% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 9.73 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is -41.98% vs 42.60% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 39.71 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is 17.52% vs 10.64% in Mar 2025

Annual - Interest
Interest 2.87 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is 189.90% vs -40.00% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.10%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has improved from Mar 2025